⌘K

Login Start Free

Home/Filings/4/0001493152-22-036060

4//SEC Filing

Bondarenko Jamieson 4

Accession 0001493152-22-036060

CIK 0001610820other

View on SEC.gov Company Profile

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 9:02 PM ET

Size

4.5 KB

Accession

0001493152-22-036060

Insider Transaction Report

Form 4

Period: 2022-12-20

BriaCell Therapeutics Corp.BCTX

Bondarenko Jamieson

Director

Transactions

Purchase
Common Shares
2022-12-20$5.35/sh+22,000$117,700→ 141,856 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

BriaCell Therapeutics Corp.

CIK 0001610820

Entity typeother

Related Parties

1

filerCIK 0001942516

Filing Metadata

Form type: 4
Filed: Dec 19, 7:00 PM ET
Accepted: Dec 20, 9:02 PM ET
Size: 4.5 KB

View on SEC.gov